Dupont Capital Management Corp Glaukos Corp Transaction History

Dupont Capital Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$44.33 - $57.82 $14,540 - $18,964	-328 Reduced 8.13%	3,707 $214,000
Q4 2021 Jan 31, 2022	BUY	$40.27 - $56.99 $162,489 - $229,954	4,035 New	4,035 $179,000
Q1 2018 May 02, 2018	SELL	$26.05 - $34.5 $1.1 Million - $1.45 Million	-42,085 Closed	0 $0
Q4 2017 Jan 31, 2018	BUY	$24.5 - $36.01 $699,352 - $1.03 Million	28,545 Added 210.82%	42,085 $1.08 Million
Q3 2017 Oct 31, 2017	BUY	$31.26 - $42.03 $423,260 - $569,086	13,540	13,540 $447,000

341

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.18B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.